Biotechnology company 4baseCare has raised $10 million in Series B funding. Co-led by Ashish Kacholia and Lashit Sanghvi, the capital raise is expected to help 4baseCare advance its solutions for personalized, precision cancer care.
With a multi-country network of labs, the company leverages genomic data and AI technologies to deliver actionable insights that guide treatment decisions and oncology research. Its offerings include genomic profiling tests and OncoTwin, which provides intelligence on treatment journeys and outcomes for similar real-world patients.
The new funding will be put toward scaling 4baseCare’s platforms and deepening its global collaborations, allowing it to capture genomic data that represents diverse populations so that it can generate evidence-backed treatment recommendations.
“This milestone isn’t just about capital, it’s about conviction. Conviction in population-relevant genomics, AI-driven cancer insights and a future where cancer care is precise, inclusive and accessible across geographies,” the company wrote in a LinkedIn post announcing the financing.
